PET/CT

Positron emission tomography/computed tomography is a hybrid nuclear medicine imaging technique that helps radiologists spot abnormal metabolic activity. PET/CT is commonly used to diagnose cancers, heart diseases and certain brain disorders, among other conditions.

Brain scans reveal single doses of nicotine inhibiting estrogen production in women

On MRI and PET brain scans, women who were exposed to a small dose of nicotine showed altered activity in the thalamus region of the brain.

Thumbnail

CRC patients with these clinical characteristics need more frequent post-op chest imaging

These patients are at greatest risk of developing lung metastases within three months of surgery.

Thumbnail

PET/CT findings predict post-treatment, radiation-induced hypothyroidism

Radiation-induced hypothyroidism is common yet underdiagnosed, potentially owing to a lack of follow-up consensus in patients treated with radiation therapy for head and neck cancers.

Thumbnail

FAPI PET/CT findings linked with risk of sudden cardiac death

Experts involved in the research suggested that these findings indicate a potential role for FAPI PET/CT imaging in detecting changes in myocardial fibrosis, noting that it could be more sensitive to earlier changes than standard cardiac MRI.

cerebral palsy PET imaging

How PET imaging could benefit children with cerebral palsy

These new findings could help providers differentiate and manage CP associated with different levels of motor impairment, authors of the study indicated.

Thumbnail

New lesion measurement assesses treatment responses more accurately than RECIST

Researchers believe the new method of assessing treatment responses could pave the way for developing new cancer therapeutics.

Thumbnail

A new Alzheimer's drug therapy appears effective. What might this mean for the future of amyloid PET?

Previously, CMS determined that coverage for patients receiving treatment was dependent on their being enrolled in a CMS-approved clinical trial under coverage with evidence development (CED).

Thumbnail

FDG-PET shown to predict pancreatic cancer outcomes prior to surgery, could guide treatment decisions

FDG-PET scans in these patients allow clinicians to determine whether the tumors are still viable or not, thus playing a significant role in making treatment decisions.